The incidence of diabetes mellitus is increasing at an alarming rate, and diabetic men already make up a quarter of the men in our own specific medically-oriented population of erectile dysfunction. The incidence of sexual dysfunction in men with diabetes approaches 50%, and this is only slightly lower in diabetic women. Hypertension is a frequent risk co-factor, being seen between 40% and 60% of diabetics in the literature. Obesity and hyperlipidemia are other frequent co-factors. Interestingly, these risk factors are the same as those for coronary artery disease. The final common pathway for most of these factors is endothelial cell dysfunction.
Introduction
Diabetes mellitus (DM) affects sexual function in both men and women. It is always listed prominently in etiological lists, noted as early as the NIH Consensus Conference on Erectile Dysfunction (ED) in 1992. 1 Several years later, the Massachusetts Aging Study noted this as one of the important clinical correlates. 2 In our study of 1000 consults for ED, DM was seen in 23% of our men. 3 
Prevalence and incidence
It is felt that roughly half of diabetic men will suffer from ED. A large study by Fedele et al, was reported from Italy and looked at nearly 10 000 men with DM. 4 Nearly 36% reported moderate to severe ED, ranging from 4.6% in young men to 45.5% in older men. The incidence was higher with increased duration of DM, poorer control, non-insulin dependent DM (NIDDM) vs insulin dependent DM (IDDM) and presence of complications. Giuliano et al, evaluated data in over 7000 men, 32% of whom had DM. 5 Of these, 67.4% felt they had ED. lnterestingly 77.9% of men who had both DM and hypertension (HTN) felt they had a problem. Also, two-thirds of the men had not been previously evaluated or treated and over two-thirds wished to be treated. This highlights the importance of having primary care physicians address the issue of ED in the office.
Sciel et al, looked at the prevalence of sexual dysfunction in a selection-free diabetic population composed of both sexes. 6 The prevalence in men was 32% for IDDM and 46% for NIDDM, while the prevalence was 18% in women with IDDM and 42% with NIDDM. Higher incidences correlated with older age and longer duration of DM.
Duration of DM and Diagnosis of ED
In Korenman's chapter on sexual dysfunction in William's textbook of endocrinology there is an interesting graph showing that the younger the patient when diagnosed with DM, the longer the interval until he develops ED. The older the man, the less is the time interval to impotence. In men over 65, the diagnosis of ED often precedes the diagnosis of DM. The reasoning is that as men age they have more co-morbid factors which can lead to ED, such as hypertension, coronary artery disease (CAD), hyperlipidemia, etc.
Pathophysiology
There are a number of biochemical mechanisms at play in the diabetic to explain sexual dysfunction.
Diabetes is well known for its micro-neurovascular changes. Many of these changes will affect the production of nitric oxide, felt to be the main transmitter in the penis, and vasculature in general, to cause vasodilatation. There are still a number of diabetics who have tobacco abuse, which will also cause a decrease in nitric oxide vasodilatation. Concurrent conditions like hypertension will do likewise, and hypertensives have an excess of angiotensin II, a powerful vasoconstrictor. Sexual function and dysfunction may be regarded as an imbalance of the various biochemical factors acting in the penis (private communication from Dr Alvaro Morales, Kingston, Ontario, Canada).
As in other chronic illnesses, hypogonadism may aggravate the situation. Penile fibrosis is especially noted in diabetics with nephropathy, especially those requiring dialysis; this is one situation that will cause severe penile fibrosis and may require a penile implant for therapy. Insulin resistance, part of the diagnosis of type 2 DM, is receiving more attention lately as an etiological agent in vascular disease and a cause of decreased endothelial function. An important fact to remember is that there are usually multiple etiological factors in any one person for sexual dysfunction and this is especially true in the diabetic. Not to be forgotten is the role of psychological factors, as brought out by Veves in a UK study which highlighted neuropathy and emotional factors in the diabetic.
Cigarette smoking is still prevalent in the US population, and the incidence is rising again in young people. 7 It is also quite prevalent in Europe and elsewhere. In a study we performed, we noted the work by Dr Rajfer who measured decreased nitric oxide in the penises of rats exposed to cigarette smoke, 8 and the relationship noted by Dr Shabsigh between cigarette smoking and vascular impotence. 9 We showed that nicotine is not the culprit, but rather some other factor, perhaps carbon monoxide. 10 Vogel showed that one cigarette will decrease brachial blood flow, as measure by ultrasound, for 50 -60 min. 11 Hypogonadism occurs in up to 5% of the male population. There are many causes including the stress of chronic disease on the body, which usually suppresses the hypothalamic -pituitary axis, so there is a low testosterone and an inappropriately low -normal LH. Reports in the past have suggested that there is a higher percentage in DM. In our study of 1000 consultations for ED, we found no difference in the diabetic males than in men with other chronic illness: approximately 5% primary hypogonadism, 25% secondary hypogonadism and 6% relative or borderline hypogonadism. 3 We also noted a higher percentage of hypogonadism in diabetics with complications.
A deficiency of nitric oxide in the penis, whether eNOS and=or nNOS, is an important final common pathway in ED of multiple etiologies. This has been shown to be true of diabetic rats, and of diabetic men. 12 Part of this may be due to the production of advanced glycation end-products (AGES) which increase free radicals and inhibit endothelial function with a decreased nitric oxide formation. Dr Seftel showed this in rabbits 13 and Dr Bucala titrated the decrease in nitric oxide production in rats. 14 Aging is associated with production of AGES, and diabetes mellitus is hallmarked by an increased production of AGES. Some have commented that diabetes is really an acceleration of the aging process. Another process of aging, which is accelerated in diabetics, is the changes in collagen of the corpora cavernosa. 15 At the molecular level, changes in apoptosis and TGFb are also associated with diabetic penile changes. 16 Most of these changes affect mechanisms involved in vasodilatation. Looking at vasoconstriction potential, Dr Christ did not find any difference in endothelin activity in diabetes. 17 
Glucose control
It is well known clinically that sexual function decreases when control of the blood sugar is poor, even when the testosterone level is normal. This was confirmed clinically as Dr Seftel found that the sexual functional score on the International Index of Erectile Function (IIEF) was inversely correlated to the level of HbA1C, a measure of average blood sugar for 3 months. 18 He found that HbA1C was an independent predictor of ED. In the UK, Dr Cartledge studied corpora cavernosal tissue and added HbA1C. 19 He felt that free radicals may be generated which decreased both eNOS and nNOS, thus giving biochemical verification to the clinical observation.
Effect of the co-morbid risk factor, hypertension
It is agreed that 40 -60% of diabetics will also suffer from hypertension. We have found that one out of every 10 men entering our clinic has this combination. Zemel estimated that HTN was 2.6 times more common in diabetics over non-diabetic subjects. 20 Hayoz stated that diabetics had blunted endothelium-dependent vasodilatation like that seen in CAD and hyperlipidemia, with or without hypertension. 21 He also reinforced the notion that advanced glucosylation products (AGPs) produced abnormal vascular responses. Including HTN to DM adds the factor of angiotensin II, a powerful vasoconstrictor, which decreases circulation by increasing oxidative stress. He felt that ACE inhibitors helped to correct this. An Italian study also showed that ACE inhibitors improved endothelial function in DM, even when HTN was not present. 22 
Hyperlipidemia
A high percentage of diabetics will have hyperlipidemia, whether it be elevated triglycerides, elevated LDL or low HDL. This carries an additional risk of heart disease but elevated lipids are also related to sexual dysfunction. Behr-Roussel and Giuliano studied rabbits and showed that the endothelial dysfunction from hypercholesterolemia was independent of aging factors. 23 An important culprit is oxidized LDL which may inactivate nitric oxide or increase its disposal as well as decrease its production. Small particle LDL has been shown to affect nitric oxide and decrease blood flow. 24 Diabetics have a predilection toward type III (small particle) LDL production. Tan has shown that this can affect endothelium-dependent and independent dilatation of blood vessels. 25 Diabetics also have elevated free fatty acid (FFA) levels, especially postprandially. This can affect vasodilatation, especially insulin induced, and Baron feels that this phenomenon may contribute to the higher incidence of HTN in DM due to the action of FFA in insulin-resistant subjects. 26 
Hormones and diabetic women
Women traditionally were felt to have some protection from coronary artery dysfunction due to estrogen production premenopausally. Baron feels that this is true, even with obesity, but not in women who have type 2 DM. 27 A study from the Joslin Clinic showed that menopause and type 2 DM impaired microvascular reactivity, when studied with acetylcholine and nitroprusside. 28 Hormone replacement therapy improved blood flow but much less in the diabetic women.
Erectile dysfunction and coronary artery disease
DM is a known risk for coronary disease. Silent ischemia was shown in 21% of one diabetic male population studied. 29 ED is also felt to be a cardiac risk. Dr Pritzker evaluated 50 men with ED and no cardiac history or symptoms; 56% were found to have a positive cardiac stress test. 30 This is not surprising as many of the medical risk factors for ED are also risk factors for cardiovascular disease (CAD), as we have shown in a recent study in our clinic. 31 
Treatment
The standard treatments are known to all. One of the important portions of the Process of Care Model calls for us to 'Modify Reversible Causes'. This means to control the DM and HTN as well as the hyperlipidemia. In some patients, this will reverse ED. If not, it will increase the success rate of other therapies. In our clinic, we noted a 56% success rate with Medicated Urethral System for Erection (MUSE) 32 and an 82% success rate with sildenafil. 33 It is also to be remembered that failure with some treatments may indicate a low testosterone level, which will reverse when appropriately treated.
